Stock Market News for October 30, 2026

At a glance

On October 30, 2026, AbbVie reported third-quarter net revenues of $17.404 billion; Chevron said third-quarter earnings were $9.9 billion; Repligen agreed to issue $1.0 billion of convertible senior notes; Valero agreed to acquire a former Houston refinery for $320.5 million.

Earnings and guidance

Imperial Oil (IMO) announced third quarter 2026 results reporting record net income of C$2,454 million and diluted earnings of C$5.11 per share.

General Dynamics (GD) reported third quarter 2026 financial results with revenue of $14.6 billion, diluted EPS of $4.49 and backlog of $220.3 billion after $98.8 billion of orders.

Regeneron Pharmaceuticals (REGN) reported third quarter 2026 financial and operating results with revenue of $5.116 billion, GAAP diluted EPS of $18.45 and an expanded Sanofi alliance that brought a $1.0 billion upfront payment recognized in Q4 collaboration revenue.

Magna International (MGA) announced strong third quarter results as sales fell 4% to $10.1 billion while net income rose to $383 million and it raised 2026 free cash flow guidance to $1.85–$1.90 billion.

BrightSpring Health Services (BTSG) reported third quarter 2026 financial results and increases full year 2026 guidance with revenue of $4,213 million, continuing-operations net income of $100.802 million and adjusted EBITDA of $228 million.

Colgate-Palmolive Company (CL) announced 3rd quarter 2026 results with net sales of $5,369 million, GAAP diluted EPS of $0.94 and nine-month operating cash flow of $2,913 million.

Canadian National Railway (CNI) delivers strong third quarter performance reporting diluted EPS of C$2.00, revenue of C$4,771 million and first-nine-month free cash flow of C$2,918 million.

Canadian National Railway (CNI) declares fourth-quarter 2026 dividend of C$0.9150 per common share, payable December 30, 2026 to holders of record on December 9, 2026.

Cboe Global Markets (CBOE) reports results for third quarter 2026 with diluted EPS of $4.08, net revenue of $712.2 million and it raised its 2026 organic net revenue growth target to the high teens.

Ingersoll Rand (IR) strengthens leadership team for next phase of growth announcing promotions: Scott Watson to senior vice president and group president, Industrial Technologies and Services North America and EMEIA, and Shaun Carlson to senior vice president and group president, Precision and Science Technologies.

Deals and acquisitions

Valero Energy (VLO) to acquire former Houston refinery from LyondellBasell for $320.5 million, subject to closing adjustments, with expected close by end of 2026 and conditions including HSR expiration or termination.

LCI Industries (LCII) board determines that the unsolicited, non-binding proposal from Monomoy Capital Partners does not constitute a superior proposal after Monomoy offered $101 per share, and reaffirmed support for its merger with Patrick Industries.

Pelthos Therapeutics (PTHS) to combine with Castle Creek Biosciences under a definitive merger agreement that gives Castle Creek holders 5,200,000 shares at closing plus up to 5,800,000 additional shares and up to $300 million in milestone payments tied to FDA approval of D‑Fi.

Financings and offerings

Repligen (RGEN) announces $1 billion private convertible senior notes transaction to issue $1.0 billion of 0.25% convertible notes due 2031, including approximately $541.4 million exchanged for 2028 notes and approximately $458.6 million issued for cash; expected close about November 6, 2026.

Hilton Grand Vacations (HGV) announces $200 million accelerated share repurchase entering an agreement for $200 million, initially receiving shares worth 80% of that amount based on the Oct. 29 closing price.

Regulatory, approvals and trials

NRX Pharmaceuticals (NRXP) receives FDA approval of preservative-free ketamine for its generic preservative-free ketamine product ahead of the November 10 goal date, with manufactured commercial supply on hand and U.S. production at Nephron Pharmaceuticals in West Columbia, South Carolina.

WisdomTree (WT) announces third quarter 2026 results reporting net income of $49.2 million, diluted EPS of $0.32 and record AUM of $171.0 billion.

Cognizant Technology Solutions (CTSH) commits more than 25,000 professionals to OpenAI delivery forming an OpenAI Frontier Capability Group of more than 25,000 professionals to deliver OpenAI products and services to clients.

Listings, delistings and capital actions

Zone Frontier (ZONE) provides shareholder update completing a 1-for-60 reverse stock split effective October 30, 2026, reducing outstanding shares to approximately 8,498,215 and updating project and financing progress.

Bluejay Diagnostics (BJDX) announces 1-for-4 reverse stock split to be effective November 3, 2026, decreasing outstanding common shares from approximately 4,468,051 to 1,117,013.